Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20226315 | 0.95 | GP6 (0.33) | GP6L3MBTL1MEN1KMT2AALDH1A1 | |
| SCHEMBL23118604 | 0.95 | KDM4E (0.42) | L3MBTL1MEN1KMT2AABCG2ATM | |
| SCHEMBL19769802 | 0.95 | KDM4E (0.42) | L3MBTL1MEN1KMT2AABCG2ATM | |
| SCHEMBL20226362 | 0.95 | GP6 (0.33) | GP6L3MBTL1MEN1KMT2AALDH1A1 | |
| SCHEMBL20226361 | 0.94 | MEN1 (0.33) | GP6L3MBTL1MEN1KMT2AALDH1A1 | |
| SCHEMBL23600345 | 0.94 | KDM4E (0.38) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL23598394 | 0.94 | KDM4E (0.38) | L3MBTL1MEN1KMT2AABCG2ATM | |
| SCHEMBL20149419 | 0.94 | KDM4E (0.38) | L3MBTL1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL23118605 | 0.94 | KDM4E (0.41) | L3MBTL1MEN1KMT2AABCG2ATM | |
| SCHEMBL19769806 | 0.94 | KDM4E (0.41) | L3MBTL1MEN1KMT2AABCG2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662196-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-26 | — | — | US | disclosed |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-17 | — | — | US | disclosed |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662196-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, SLCO4C1 | GP6 4511/4885L3MBTL1 2317/4885MEN1 4244/4885 |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, SLCO4C1 | GP6 4511/4885L3MBTL1 2317/4885MEN1 4244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.